The vascular parkinsonism market is forecasted to grow from USD 319.5 million in 2025 to USD 538.1 million by 2035, at a CAGR of 6.20% during the forecast period. The growth is being driven by the ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...

The modern boxing comeback is a perfect storm where the fighter’s timeless need for purpose has collided with an economy that ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat ...

July 10, 2025 Stephen Braun, 65 of Winnipeg formerly of Altona passed away Tuesday, July 1st in Winnipeg. He is survived by ...

KATHMANDU, July 9: The citizens enrolled in the health insurance program would receive upto Rs 200,000 for their health care ...

Vascular parkinsonism differs from Parkinson's disease in terms of clinical presentation and findings on imaging; patients with vascular parkinsonism also have poorer treatment response and prognosis.

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterised by motor dysfunction (parkinsonism) and several non-motor features. Dysautonomia is a significant non-motor feature ...

An association between Gaucher disease and Parkinson disease has been demonstrated by the concurrence of Gaucher disease and parkinsonism in rare patients and the identification of glucocerebrosidase ...